Radiotherapy & Oncology
Volume 93, Issue 3 , Pages 534-538, December 2009

Erosive potential of saliva stimulating tablets with and without fluoride in irradiated head and neck cancer patients

  • Christel Lajer

      Affiliations

    • Department of Otolaryngology Head and Neck Surgery, Rigshospitalet, University of Copenhagen, Denmark
    • Corresponding Author InformationCorresponding author. Address: Department of Otolaryngology Head and Neck Surgery, University of Copenhagen, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen Ø, Denmark.
  • ,
  • Christian Buchwald

      Affiliations

    • Department of Otolaryngology Head and Neck Surgery, Rigshospitalet, University of Copenhagen, Denmark
  • ,
  • Birgitte Nauntofte

      Affiliations

    • Department of Oral Medicine, Faculty of Health Science, University of Copenhagen, Denmark
  • ,
  • Lena Specht

      Affiliations

    • Department of Oncology, Rigshospitalet, University of Copenhagen, Denmark
  • ,
  • Allan Bardow

      Affiliations

    • Department of Oral Medicine, Faculty of Health Science, University of Copenhagen, Denmark
  • ,
  • Thorbjörg Jensdottir

      Affiliations

    • Department of Oral Medicine, Faculty of Health Science, University of Copenhagen, Denmark

Received 6 February 2009; received in revised form 8 June 2009; accepted 27 June 2009. published online 21 July 2009.

Abstract 

Background

Patients irradiated in the head and neck region often suffer from severe dry mouth and use acidic saliva stimulating products, which may cause erosion of teeth.

Purpose

To determine saliva stimulating effects and erosive potential (EP) of acidic saliva stimulating tablets (Xerodent™) with and without fluoride in irradiated head and neck cancer patients.

Materials and method

Nineteen irradiated patients (median age 57years) sucked Xerodent™ tablets with and without fluoride. Saliva collections were divided into three 10-min sessions in the sequence: unstimulated whole saliva, Xerodent™ stimulated saliva without fluoride, and with fluoride. Saliva pH was determined without loss of CO2 and in combination with inorganic measures used to calculate the degree of saturation of hydroxyapatite (HAp) and fluorapatite (FAp). EP was determined directly in all saliva samples by monitored dissolution of HAp crystals.

Results

Saliva flow rates increased significantly (15-fold) when sucking both tablets (p<0.001). Major changes in saliva composition caused undersaturation of HAp in some samples. However, no dissolution of HAp occurred in the saliva obtained with any of the two tablets. This was most likely due to the limited drop in pH resulting in saliva that was still supersaturated with respect to FAp.

Conclusion

Both Xerodent™ with and without fluoride were evaluated as non-erosive, however, for additional caries protection the fluoride variant is preferable.

Keywords: Head and neck cancer, Radiotherapy, Xerostomia, Saliva stimulation, Dental erosion

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0167-8140(09)00342-9

doi:10.1016/j.radonc.2009.06.028

Radiotherapy & Oncology
Volume 93, Issue 3 , Pages 534-538, December 2009